Data For Adipose Stem Cell Heart Attack Trial Published In JACC

Cytori Therapeutics (NASDAQ: CYTX) has announced the publication of previously reported six-month outcomes from APOLLO, the Company’s European clinical trial evaluating adipose-derived stem and regenerative cells (ADRCs) in patients with acute myocardial infarction (heart attack or AMI), as Research…